Regulators are clearing the path for AI that writes its own clinical notes, shifting the technology from a simple second pair of eyes to an active administrative partner.
High-tech cancer diagnostics are currently a luxury of the wealthiest health systems, but a shift in how we analyze basic tissue slides could soon level the playing field.
A new algorithm can spot hyperacute stroke tissue changes on cheap, standard CT scans, but it struggles to map the exact boundaries of smaller lesions.
Clinical AI models are increasingly being outperformed by, or failing to improve upon, traditional statistical methods and established clinical formulas in critical predictive tasks.